The Immune Tolerance of Cancer is Mediated by IDO That is Inhibited by COX-2 Inhibitors Through Regulatory T Cells

Authors

Keywords

Journal

Volume 32, Issue 1, Pages 22-28

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2008-12-18

DOI

10.1097/cji.0b013e31818ac2f7

Explore over 38,000 international journals covering a vast array of academic fields.

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now